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              Abstract 
Background:  Critically ill patients with diabetes are at increased risk of development of complications. But the 
impact of diabetics on ICU outcome is unclear. Furthermore, there is scarcity of data from Indian ICU.  In this 
study, we aimed at assessing the relationship between  diabetes mellitus with specific ICU outcome in terms of 
duration of ICU stay, ICU mortality and ICU cure rate. We also tried to correlate the value of the capillary blood 
glucose level at the time of ICU admission with the duration of ICU stay. Materials & Methods:  This was a 
hospital record based observational study. Anonymized data collection was done from the records of patients who 
were admitted in the ICU of Burdwan Medical College and Hospital during  January 2020 to March 2020. Data 
regarding the capillary blood glucose value during the time of ICU admission, duration of ICU stay and ICU 
mortality were collected from the record section. Results:  Among the retrieved data of 246 patients, 84 patients 
were diabetics (34.15%). The duration of ICU stay was found to be significantly higher among the diabetics 
population than those of non-diabetics. (p =.01) A moderately positive correlation was found between the capillary 
blood glucose level at the time of  ICU admission and duration of ICU stay. However, no statistically significant 
difference was found in terms of mortality and ICU cure-rate between the two groups. Conclusion:  From the 
present study we came to a conclusion that duration of ICU stay is influenced by the presence of diabetes with a 
positive correlation of ICU admission time capillary blood glucose level with the duration of ICU stay. Both ICU 
mortality and ICU cure-rate were independent of diabetes. 
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Introduction 
 
Diabetes Mellitus (DM) refers to a group of metabolic 
disorders that share the common manifestation of 
hyperglycemia. Diabetes mellitus is the major 
endocrine epidemic of modern time.[1]The number of 
people suffering from diabetes has surged from 108 
million in 1980 to 463 million in 2019. 
______________________ 
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Additionally, the global prevalence of diabetes has 
risen from 4.7% in 1980 to 9.3% in 2019.[2]  What 
worries us more, is the fact that India contributes 
significantly to this global epidemic of diabetes. 
Harbouring 69.2 million diabetes patients with a 
prevalence of 7.8%, India accounts for 16-17% of the 
world’s total diabetics.[3] 
On the other hand, hospitals across India cater to 5 
million patients who need ICU admission per year. 
Unfortunately, 18.1% of these critically ill patients end 
up as non- survivors and another significant proportion 
are discharged with some sort of sequelae. What 
worsens this worrisome statistics is the prevalence of 
diabetes in these critical patients. The proportion of 
patients with diabetes admitted to the ICU is growing 
as a result of the worldwide increase of type 2 
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diabetics. Study reported that about 38.73% of ICU 
patients are hyperglycemic in India.[4] It is now well-
known that diabetes patients admitted to ICU are more 
prone to develop complications.[5-7] A strong 
association between diabetes and ICU bloodstream 
infection is established.[8] This may be attributed to 
the hampered immune cell functions associated with 
the disease.[9-10] Diabetes itself leads to a higher 
incidence of nearly all comorbidities including renal, 
cardiovascular and neuropathic diseases.[11] Further 
more, diabetic complications can directly impact the 
outcome of patients in ICU. However, the effect of 
stand-alone diabetes on a patient’s risk of ICU 
mortality has been debated. A recent meta-analysis of 
141 studies by Siegelaar et al. suggested that having a 
diagnosis of diabetes in the ICU does not itself directly 
lead to increased mortality in most ICU settings.[11] 
Another study demonstrated that higher HbA1c values 
and admission glucose values were predictive for 
mortality of ICU patients.[12] 
So it is evident that there is serious need of more such 
investigations for coming to a specific conclusion. 
Moreover, Indian population varies largely from the 
western population owing to the diversity in the genetic 
pool and environmental factors which intensify the 
need of such study in our country. But unfortunately 
such kind of work is grossly missing in the Indian 
subcontinent. 
This current study has been designed to establish 
association between presence of diabetes with ICU 
outcome in terms of duration of ICU stay and other 
related parameter like mortality, cure-rate at the time of 
discharge by gathering data from a tertiary care 
medical college in West Bengal, India. 
 
Objective 
The Primary objective of this study was to assess the 
relationship of Diabetes Mellitus with different ICU 
outcomes. To be specific we tried to establish any 
association between the presence of Diabetes with ICU 
mortality, duration of ICU stay, ICU cure rate. A 
secondary objective was included to establish 
correlation between the capillary blood glucose level at 
the time of ICU admission ICU and the duration of 
ICU stay. 
 
Materials and Methods 
This was an observational, retrospective, record based 
study. The study was performed after approval from 
the institutional ethics committee of Burdwan Medical 
College. 
Ethical clearance was obtained from the institutional 
ethics committee of Burdwan Medical College. For the 
study purpose the records of the patients who were 
admitted in the BMC critical care unit during the 
period of January 2020 to March 2020 were 
considered. The study did not involve any direct 
interaction with patients and hence data collection was 
anonymized. So, waiver of consent was obtained from 
the IEC. Patients having no record about blood glucose 
level during their ICU stay were excluded from the 
study. 
Following records were collected from the patients’ 
charts. age, gender, occupation, date of admission, 
duration of hospitalization, history of diabetes mellitus 
at the time of admission, Capillary blood glucose level 
at the time of admission, Lipid profiles, all 
measurements regarding blood glucose taken during 
ICU stay, date of discharge from hospital or date of 
death in ICU. Eligible patients were  subsequently 
classified into two groups on the basis of presence or 
absence of Diabetes Mellitus as inferred from the 
glycemic Measurements during ICU stay.The current 
case definition of Diabetes Mellitus provided by the 
American Diabetic Association was taken into 
consideration. All the collected data were tabulated and 
analysed for drawing inference. 
Statistical Analysis 
Fisher’s exact test was used for the assessment of 
association between Diabetes Mellitus and mortality. 
The same test was also applied for assessing 
relationship between Diabetes Mellitus and ICU cure 
rate.  For the evaluation of relationship between 
Diabetes Mellitus and duration of ICU stay, the mean 
duration of ICU stay of the two groups were compared 
using Independent Sample t Test. 95% Confidence 
interval was considered to be statistically significant. It 
was apart of the statistical analysisplan to obtain a 
scatter plot to identify any linear relationship  between 
the  capillary blood glucose level at the time of ICU 
admission and the duration of ICU stay and in case of a 
linear relationship, calculating a Pearson’s  product 
moment correlation coefficient ‘r’to determine the 
strength of the relationship. 
Results 
A total number of 246 patients were eligible for the 
study.  Among them 84 patients (34.15%) were found 
to be diabetics and the rest 162 patients were non-
diabetics. Baseline characters are described in table 1 
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and table 2. There was no significant difference 
between the two groups in terms of age, gender, lipid 
profile and occupation. However, there was significant 
difference in the distribution of baseline morbidities 
between the two groups. (Refer to table 1 and 2)  
Table 1: Baseline characteristics of the diabetics and non-diabetics group 
Base line 
characteristics 
Diabetics 
84, 34.15% 
Non-Diabetics 
162, 65.85% 
Total 
246, 100% 
P- value 
Age 51.29+1.59  55.09+2.42 53.98+1.36 0.313 
Gender 
Male 
Female 
 
M: N=46,54.7% 
 F: N= 38, 45.3% 
 
M: N=76, 46.9% 
F: N= 86, 53.1% 
 
M: N=122,49.6% 
F: N=124,51.4% 
 
0.06 
0.07 
Occupation 
Farmer 
Labour 
Home-maker 
Student 
Business-man 
Teacher 
Service person 
 
22 (26.5%) 
12 (14.3%) 
19 (22.3%) 
06 ( 7.1%) 
10 (11.9%) 
10 (11.9%) 
05 (6%) 
 
51 (31.5%) 
22 (13.6%) 
35 (21.6%) 
20 (12.3%) 
15 (9.3%) 
12 (7.4%) 
07 (4.3%) 
 
73 (29.7%) 
34 (13.8%) 
54 (22%) 
26 (10.6%) 
25 (10.2%) 
22 (8.9%) 
12 (4.8%) 
 
0.086 
0.233 
0.132 
0.043 
0.342 
0.012 
0.087 
Lipid profile 
Total cholesterol 
Triglyceride 
HDL-C 
LDL-C 
 
194.23+2.23 
133.08+3.21 
43.04+ 3.11 
89.08+ 2.03 
 
189.35+4.23 
129.25+2.22 
45.05+2.34 
87.09+2.23 
 
191.12+3.12 
130.98+2.89 
44.81+2.09 
87.98+2.78 
 
0.086 
0.128 
0.243 
0.348 
 
CI= 95% and 80% power 
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Table 2: Baseline morbidity leading to ICU admission between diabetics and non-diabetics 
Baseline 
characteristics 
Diabetics 
84, 34.15% 
Non-diabetics 
162, 65.85% 
Total 
246, 100% 
P- value 
Root cause of ICU admission 
DKA& HHS 31 (36.9%) 00 (0%)  31 (12.6%) .001 
CVA 04 (4.8%) 08 (4.9%) 12 (4.9%) .012 
Meningitis 04 (4.8%) 12 (7.40%) 16 (6.5%) .009 
Gynaecological 08 (9.6%) 22 (13.6%) 30 (12.1%) .003 
AKI 06 (7.1%) 02 (1.2%) 08 (3.2%) .021 
Cardio-vascular 08 (9.6%) 29 (17.9%) 37 (15%) .061 
Hepatic failure 03 (3.6%) 09 (5.6%) 12 (4.9%) .009 
Respiratory failure 09 (10.7%) 32 (19.7%) 41 (16.7%) .044 
Surgical  04 (4.8%) 14 (8.6%) 18 (7.3%) .004 
Intoxication 01 (1.2%) 12 (7.4%) 13 (5.3%) .001 
Infective 03 (3.6%) 14 (8.6%)  17 (6.9%) .009 
Others 03 (3.6%) 08 (4.9%) 11 (4.5%) .032 
CI= 95% and 80% power 
It was found that 28.53 % patients among diabetics 
ended as non-survivors in comparison to 22.22% in 
non-diabetics. Tough the proportion of death among 
diabetics was higher, there was no statistically 
significant difference of mortality between the two 
group as derived from the Fisher’s exact test. Figure1 
show the graphical representation of the relationship 
between diabetes mellitus and ICU mortality. 
 
Figure 1: Mortality was found to be independent of the presence of diabetes (p = 0.380) 
CI=95% and 80% power 
 
However, comparison between the two groups on mean duration of ICU stay revealed a statistically significant 
longer ICU stay among diabetics.Figure 2 shows the comparison of the two mean ICU Stays. 
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Figure 2: Mean duration of ICU stay was higher among diabetics. This difference was statistically significant 
(p = 0.001) 
CI=95% and 80% power 
The ICU cure rate was measured by the presence or absence of sequelae at the time of discharge from ICU. An 
absence of sequelae indicated cure.No statistically significant difference was found between the two groups on the 
basis of ICU cure rate. Figure 3 shows the comparison of the ICU cure rates between the two groups. 
 
 
Figure 3: ICU cure rate was independent of the presence of Diabetes Mellitus. (p = 0.493) 
CI=95% and 80% power 
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A moderately positive correlation was found to be present between the capillary blood glucose level at the time of 
ICU admission and the duration of ICU stay as derived from the Pearson product moment coefficient. (Referto 
figure 4) 
 
Figure 4: A moderate positive correlation (r = 0.41) was established between the value of RBS at the time of 
admission and the duration of ICU stay 
Discussion 
We performed a retrospective, record based study to 
find out the effect of Diabetes Mellitus on different 
ICU outcomes.The finding of our study showed that 
presence of Diabetes Mellitus was associated with the 
mean duration of ICU stay. A significant correlation 
was also happened to exist between the value of 
capillary blood glucose level at the time of ICU 
admission and the duration of ICU stay. 
In a meta-analysis compiling of 141 studies, which was 
conducted by Siegelaar SE et.el. found no association 
between the presence of stand- alone Diabetes Mellitus 
and risk of mortality.[12] 
Tough the proportion of death among diabetics was 
higher in our study, no statistically significant 
difference of mortality between the two groups were 
established. It was found that 28.53 % patients among 
diabetics ended as non-survivors in comparison to 
22.22% in non-diabetes. The absence of statistical 
significance might have been resulted due to relatively 
small sample size. 
Dharmalingam M. et.al. reported that about 38.73% of  
ICU patients are hyperglycaemic in India, which was 
reflected in this study. 
Stress-induced hyperglycemia has been linked to 
increased mortality in hospitalized patients.[13,14] It 
occurs due to counter-regulatory hormones and 
cytokines leading to increased gluconeogenesis and 
insulin resistance.[15] Zaman A el.al. showed that 
dysglycaemia occurring due to admission in the 
intensive care unit were associated with overall longer 
length of stay in all patients.[16] In our study also this 
stress induced hyperglycaemia might have played a 
confounding role in the outcome variables. 
According to a study conducted by Mahmoodpoor A 
el.al., HbA1c happened to be significantly associated 
with ICU mortality in previously undiagnosed Diabetes 
Mellitus patients.[13] The unavailability of data 
regarding glycated haemoglobin remained a limitation 
in our study. 
 
Conclusion 
Diabetes Mellitus was associated with increased mean 
duration of ICU stay. A significant linear correlation 
was also existed between the value of RBS at the time 
of ICU admission and the duration of ICU stay. There 
were no statistically significant difference in ICU 
mortality and ICU cure rate between diabetics and non-
diabetics though higher proportion of diabetics ended 
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up as non survivors. Further studies involving larger 
study population is recommended. 
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